chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 71.0
Sex: M
Vaccine: FLU3, PPV
Symptoms: Unevaluable event
Clinical narrative: A healthcare professional reported that a patient received an injection of Pnu-Imune 23 and Fluzone (Aventis Pasteur Inc.) on 11/08/00. Subsequently, the patient developed a local reaction which the reporter did not describe at the site of Pnu-Imune 23 administration. No further info was available at the date of this report. This is 1 of 3 patients who experienced this event following receipt of Pnu-Imune-23 lot 466-440. Follow up info received from the physician on 03/27/01 indicated that the patient was 71 year old male. He was seen by the physician and recovered.
Age: 9.0
Sex: M
Vaccine: PPV
Symptoms: Injection site reaction
Clinical narrative: A healthcare professional reported that a 9 year old child received an injection of Pnu-Imune 23 on 11/03/00. Subsequently, the child developed an injection site reaction which the reporter did not describe. This is 1 of 3 patients from this facility who experienced this event following receipt of Pnu-Imune 23 lot 466-440. Follow-up info received from the physician on 03/27/01, indicated that the patient was a  male and he recovered.
Age: 68.0
Sex: M
Vaccine: PPV
Symptoms: Furuncle, Injection site pain, Injection site reaction
Clinical narrative: A nurse reported that a 68 year old physician received an injection of Pnu-Imune 23 on 10/11/00. Approx. 24 hours, post vax, he developed an injection site reaction characterized by a boil and pain that lasted for 4 to 5 days. He recovered. This is 1 of 2 pts from this facility who had an adverse experience following receipt of Pnu-Imune 23, lot 468136.
Age: 67.0
Sex: M
Vaccine: PPV, PPV
Symptoms: Injection site erythema, Injection site pain, Injection site warmth
Clinical narrative: A pharmacist reported that a 67 year old male received an injection of Pnu-Imune 23 vaccine on 3/24/01. The next day, he developed an injection site reaction characterized by an area of erythema, warmth and soreness. This is 1 of 3 pts from this facility who experienced an injection site reaction following receipt of Pnu-Imune 23, "probably" (lot 467412). The reporter was not certain of the lot number. No further information was available at the date of the report. (See HQ0558207MAY2001 and HQ0560407MAY2001).
Age: 67.0
Sex: M
Vaccine: PPV, PPV
Symptoms: Injection site erythema, Injection site pain
Clinical narrative: A pharmacist reported that a 67 year old male received an injection of Pnu-Imune 23 vaccine on 03/24/01. That same day, he developed an injection site reaction characterized by erythema and pain. These symptoms resolved the following evening. This is 1 of 3 patients from the same facility who experienced an injection site reaction following receipt of Pnu-Imune 23, "probably" lot 467-412. The reporter was not certain of the lot number. No additional info is available at the time of this report.
Age: 72.0
Sex: M
Vaccine: PPV, PPV
Symptoms: Injection site pain, Injection site swelling
Clinical narrative: A pharmacist reported that a 72 year old male received an injection of Pnu-Imune 23 on 03/24/01. That same day, he developed an injection site reaction characterized by swelling and pain. This is 1 of 3 patients from this facility who experienced this event following receipt of Pnu-Imune 23 "probably" lot 467-412.The reporter was not certain of the lot number. No further info was available at the date of this report.
Age: 72.0
Sex: M
Vaccine: PPV, PPV
Symptoms: Injection site oedema, Injection site pain
Clinical narrative: A pharmacist reported that a 72 year old male received an injection of Pnu-Imune 23 on 03/24/01. That same day, he developed an injection site reaction characterized by swelling and pain. This is 1 of 3 patients from this facility who experienced this event following receipt of Pnu-Imune 23 "probably" lot 467-412.The reporter was not certain of the lot number. No further info was available at the date of this report.
Age: 11.0
Sex: F
Vaccine: PPV, PPV
Symptoms: Cellulitis
Clinical narrative: A nurse reported that an 11 year old female received an injection of Pnu-Imune 23 vaccine on 05/10/01. That same day, she developed fevers which rose to 104 degrees F and a "very large" injection site reaction measuring 50 mm by 64 mm. Concomitant therapy included Rhinocort (budesonide), Claritin (loratadine), Zantac (ranitidine hydrochloride), Albuterol ( salbutamol) and Advair Viscous. The child was subsequently hospitalized. No further info was available at the date of this report.
Age: 11.0
Sex: F
Vaccine: PPV, PPV
Symptoms: Injection site reaction, Pyrexia
Clinical narrative: A nurse reported that an 11 year old female received an injection of Pnu-Imune 23 vaccine on 05/10/01. That same day, she developed fevers which rose to 104 degrees F and a "very large" injection site reaction measuring 50 mm by 64 mm. Concomitant therapy included Rhinocort (budesonide), Claritin (loratadine), Zantac (ranitidine hydrochloride), Albuterol ( salbutamol) and Advair Viscous. The child was subsequently hospitalized. No further info was available at the date of this report.
Age: 53.0
Sex: M
Vaccine: PPV, PPV
Symptoms: Pyrexia, Rash
Clinical narrative: Information has been received from a 53 year old consumer with allergies to NSAID's, who on 12/21/00, was vaccinated with one dose of pneumococcal vaccine polyvalent. It was noted that the patient was not sure if the vaccine was pneumococcal vaccine polyvalent, he just stated "pneumonia shot". A couple of days later the patient developed a rash under the armpits and then it started to spread to his arms and legs. The patient sought medical attention from a dermatologist. The patient had received a pneumonia shot thirteen years ago and had no side effects. Additional info has been requested.  The follow up info received on 7/9/02 states it was reported that the vaccine was pneumococcal vaccine 23 polyvalent. On an unspecified date, the pt also experienced fever. It was reported that no seriour criteria were met. This was originally reported by a physician. Follow up info received from the physician indicated that the pt recovered. On an unspecified date. No further info is available.
Age: 53.0
Sex: M
Vaccine: PPV, PPV
Symptoms: Rash
Clinical narrative: Information has been received from a 53 year old consumer with allergies to NSAID's, who on 12/21/00, was vaccinated with one dose of pneumococcal vaccine polyvalent. It was noted that the patient was not sure if the vaccine was pneumococcal vaccine polyvalent, he just stated "pneumonia shot". A couple of days later the patient developed a rash under the armpits and then it started to spread to his arms and legs. The patient sought medical attention from a dermatologist. The patient had received a pneumonia shot thirteen years ago and had no side effects. Additional info has been requested.  The follow up info received on 7/9/02 states it was reported that the vaccine was pneumococcal vaccine 23 polyvalent. On an unspecified date, the pt also experienced fever. It was reported that no seriour criteria were met. This was originally reported by a physician. Follow up info received from the physician indicated that the pt recovered. On an unspecified date. No further info is available.
Age: 31.0
Sex: M
Vaccine: HEPA
Symptoms: Dyspnoea, Throat tightness
Clinical narrative: After this patient received Hep A immunization approximately 1 hour later returned complaining of slight difficulty in breathing and throat tightening. Patient given Benadryl with good results.
Age: 1.0
Sex: F
Vaccine: DTAP, HEP, HIBV, MMR, OPV
Symptoms: Abnormal behaviour, Contusion, Insomnia, Irritability, Mood swings
Clinical narrative: After vaccinated, symptoms were bruising easily, irritable, mood swings, crying, sleeplessness, change of personality from happy quiet child to irrational wild like behavior. Diagnosed 08/12/97 with ITP (idiopathic thrombocytopenic purpura) - low platelets at chronic low, bruising, petechia under 20,000. Treatments have ranged from prednisone multiple times, IVIG multiple (20) times, methylprednisolone (5x) no effect.
Age: 1.0
Sex: F
Vaccine: DTAP, HEP, HIBV, MMR, OPV
Symptoms: Petechiae, Platelet count decreased, Thinking abnormal, Thrombocytopenic purpura
Clinical narrative: After vaccinated, symptoms were bruising easily, irritable, mood swings, crying, sleeplessness, change of personality from happy quiet child to irrational wild like behavior. Diagnosed 08/12/97 with ITP (idiopathic thrombocytopenic purpura) - low platelets at chronic low, bruising, petechia under 20,000. Treatments have ranged from prednisone multiple times, IVIG multiple (20) times, methylprednisolone (5x) no effect.
Age: 12.0
Sex: F
Vaccine: HEP
Symptoms: Convulsion, Encephalitis, Encephalopathy, Headache, Pyrexia
Clinical narrative: Three days after Hep B vaccine #2 (1st vaccine 1 year earlier) fever of 104, headache, seizure. Diagnosed with viral meningo-encephalitis. The discharge summary states encephalopathy.
Age: 7.0
Sex: M
Vaccine: PNC
Symptoms: Cellulitis, Injection site reaction
Clinical narrative: This patient had cellulitis at the injection site from administration of pneumococcal vaccine Prevnar. Required antibiotics to treat the cellulitis.
Sex: U
Vaccine: FLU3, PPV
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Within 24 hours of vax, pt developed a "severe" injection site reaction characterized by swelling, redness and tenderness. No further info was available at date of this report. Manufacturer's Comment: The reporter indicated that 5 pts experienced this event; howeer, they are not presently identifiable. Addtl reports will be generated when identifying info is provided.
Age: 37.0
Sex: M
Vaccine: FLU3, PPV
Symptoms: Injection site reaction, Pyrexia
Clinical narrative: The day following vax pt developed a fever of 102F and an injection site reaction at the site of Pnu-Imune-23 administration which the reporter did not describe. On 12/7/00 pt was seen by MD and treated with Motrin, Benadryl, Tylenol and applications of cold compresses. A copy of this report has been forwarded to Aventis Pasteur Inc., manufacturer of Fluzone. Follow-up info recvd 6/18/01 indicated that the pt received Pnu-Imune 23 on 12/6/00. He recovered.
Age: 66.0
Sex: F
Vaccine: FLUX, PPV
Symptoms: Injection site erythema, Injection site pain
Clinical narrative: A nurse reported that pt received pneumococcal (manufacturer unk) and 1993-94 formula influenza (manufacturer unk) vaccines in 1993 and subsequently developed an injection site reaction characterized by redness and soreness. She recovered.
Age: 67.0
Sex: U
Vaccine: FLU3, PPV
Symptoms: Injection site erythema, Injection site pain, Urticaria
Clinical narrative: Two days post vax the pt developed an injection site reaction at the Pnu-Imune 23 site described as "a large red wheal 3 inches in diameter that became sore radiating down to the elbow." Note: This is 1 of 2 pts reported by the same reporter. See HQ6352724JAN2001 for the report on the other pt.
Age: 88.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Pruritus
Clinical narrative: Two days post vax pt developed an injection site reaction characterized by redness, pain, swelling and itching at the site of Pnu-Imune 23 administration. The MD instructed pt to treat with Motrin and applications of ice. That same day she was seen in ER and treated with an unspecified antibiotic. On 11/2/00, pt was seen by MD who noted "some" improvement of her symptoms. The pt had previously recvd an injection of Pnu-Imune 23 in 1993. This is 1 of 4 pts from this facility who experienced an adverse event following receipt of 2 different lots of Pnu-Imune 23. Follow-up info recvd from MD on 3/20/01 indicated the pt recovered.
Age: 65.0
Sex: F
Vaccine: FLU3, PPV, FLU3, PPV
Symptoms: Injection site erythema, Injection site oedema
Clinical narrative: A nurse reported that a 65 year old female received an injection of Pnu-Imune 23 and Fluzone (Aventis Pasteur Inc.) vaccines on 11/13/00. Within 24 hours of vaccine administration, the patient developed an injection site reaction characterized by redness and swelling. The specific sites of vaccine administration were not reported. This is 1 of 2 patients from this facility who experienced an adverse reaction following receipt of Pnu-Imune 23 lot 469-133.
Age: 65.0
Sex: F
Vaccine: FLU3, PPV, FLU3, PPV
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: A nurse reported that a 65 year old female received an injection of Pnu-Imune 23 and Fluzone (Aventis Pasteur Inc.) vaccines on 11/13/00. Within 24 hours of vaccine administration, the patient developed an injection site reaction characterized by redness and swelling. The specific sites of vaccine administration were not reported. This is 1 of 2 patients from this facility who experienced an adverse reaction following receipt of Pnu-Imune 23 lot 469-133.
Age: 72.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Cellulitis, Injection site reaction
Clinical narrative: A nurse reported that a 72 year old female received an injection of Pnu-Imune 23 and Influenza virus vaccine (manufacturer unknown) on 11/03/00. Subsequently,the patient developed cellulitis at the site of Pnu-Imune 23 administration. She was treated with Advil , Benadryl, and applications of warm compresses. This is 1 of 3 patients from this facility who developed an injection site reaction following receipt of Pnu-Imune 23 lot 470-588. Follow-up info received from the physician on 03/14/01, indicated that the patient experienced the adverse event on 11/04/2000. She was seen by the physician and recovered.
Sex: F
Vaccine: FLU3, PPV
Symptoms: Asthenia, Dizziness, Headache, Injection site erythema, Injection site warmth
Clinical narrative: A female reported that she received Pnu-Imune 23 and Influenzae virus vaccines on 12/02/00. That same day, she experienced a headache, feeling sick to the stomach, weakness, dizziness, and a stiff neck. She also experienced "severe" pain from her right shoulder extending down her hand and up to the side of her neck to her skull. In addition, her hand became "purple in color" and she developed an injection site reaction characterized by redness and warmth at the site of Pnu-Imune 23 administration. She was seen by a physician who reportedly attributed the events to a reaction to the Pnu-Imune 23 injection.
Sex: F
Vaccine: FLU3, PPV
Symptoms: Musculoskeletal stiffness, Nausea, Pain, Shoulder pain, Skin discolouration
Clinical narrative: A female reported that she received Pnu-Imune 23 and Influenzae virus vaccines on 12/02/00. That same day, she experienced a headache, feeling sick to the stomach, weakness, dizziness, and a stiff neck. She also experienced "severe" pain from her right shoulder extending down her hand and up to the side of her neck to her skull. In addition, her hand became "purple in color" and she developed an injection site reaction characterized by redness and warmth at the site of Pnu-Imune 23 administration. She was seen by a physician who reportedly attributed the events to a reaction to the Pnu-Imune 23 injection.
Age: 57.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Injection site erythema, Injection site oedema, Injection site pain
Clinical narrative: A 57 year old female received Pnu-Imune 23 and Flu-Shield (2000- 2001 Formula) on 12/12/00. The next day, she developed an injection site reaction characterized by redness, swelling, and tenderness below the Pnu-Imune 23 injection site.
Age: 43.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Erythema, Pruritus, Urticaria
Clinical narrative: A 43 year old female reported that she received Pnu-Imune 23 and Influenza virus vaccine (manufacturer unknown) on 12/14/00. Within "a few hours" of vaccine administration, she developed an injection site reaction characterized by a "large" hive that swelled to the size of a "baseball", itching, and redness. The reporter indicated that both vaccines were administered in the left deltoid.
Age: 55.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Injection site hypersensitivity, Injection site oedema, Injection site pain, Injection site warmth
Clinical narrative: A medical assistant reported that a 55 year old female received an injection of Pnu-Imune 23 on 01/04/01. The following day, she developed an injection site reaction characterized by tenderness, swelling, redness, and warmth. She was treated with Benadryl and applications of moist heat. The patient recovered by 01/09/01. This is 1 of 2 patients from this facility who experienced this event following receipt of Pnu-Imune 23 lot 466-440. Follow-up info received from the physician on 05/29/01, indicated that the patient received Pnu-Imune 23 and Fluzone vaccines on  01/04/2001. The patient developed the injection site reaction at the site of Pnu-Imune 23 administration.
Sex: U
Vaccine: FLU3, PPV
Symptoms: Injection site erythema, Injection site pain, Urticaria
Clinical narrative: A pharmacist reported that a pt (age and gender unspecified) received injections of Pnu-Imune 23 and Flu Shield (2000-2001 Formula) on 1/19/01. On an unspecified date, the pt developed an injection site reaction at the Pnu-Imune 23 site described as "a large red wheal, 3" in diameter that became sore, radiating down to the elbow". Note: This is 1 of 2 pts reported by the same reporter. See HQ6999308FEB2001 for the report on the other pt.
Age: 43.0
Sex: M
Vaccine: FLU3, PPV
Symptoms: Hypotension, Injection site reaction, Injection site swelling, Injection site warmth, Pyrexia
Clinical narrative: A physician reported that a male pt received an injection of Pnu-Imune 23 and subsequently, developed tachycardia and a fever of 99.8F. He also developed an injection site reaction characterized by swelling and warmth. His blood pressure was 112/74. Follow-up information received from the physician on 4/3/01, indicated that a 43 year old male received Pnu-Imune 23 and Fluvirin (Evans) vaccines on 12/5/00. The following day, he developed tachycardia, fever and an injection site reaction at the site of Pnu-Imune 23 administration. The pt recovered.
Age: 43.0
Sex: M
Vaccine: FLU3, PPV
Symptoms: Tachycardia
Clinical narrative: A physician reported that a male pt received an injection of Pnu-Imune 23 and subsequently, developed tachycardia and a fever of 99.8F. He also developed an injection site reaction characterized by swelling and warmth. His blood pressure was 112/74. Follow-up information received from the physician on 4/3/01, indicated that a 43 year old male received Pnu-Imune 23 and Fluvirin (Evans) vaccines on 12/5/00. The following day, he developed tachycardia, fever and an injection site reaction at the site of Pnu-Imune 23 administration. The pt recovered.
Age: 70.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Antinuclear antibody positive, Arthralgia, Joint effusion, Laboratory test abnormal, Myalgia
Clinical narrative: A physician reported that a 70 year old female received Pnu-Imune 23 and Fluzone vaccines on 11/13/00. A "few" minutes, post vax, the pt developed arthritis type symptoms described as arthralgia and myalgia of both arms and effusion of her right shoulder. On 11/17/00, she was seen by the physician who "tapped" her shoulder and treated her with ibuprofen and Tylenol. The reporter stated that blood work showed an elevated ANA and "some of her CBC was abnormal". The reporter also indicated that this was a new pt and blood levels "could have been elevated prior to vaccination". This is 1 of 2 pts from this facility who had an adverse experience following receipt of Pnu-Imune 23 (lot 466786).
Age: 63.0
Sex: F
Vaccine: FLU3, PPV, FLU3, PPV
Symptoms: Feeling cold, Hot flush, Injection site erythema, Injection site swelling, Myalgia
Clinical narrative: A nurse reported that a 63 year old female received Pnu-Imune 23 and Fluzone vaccines on 11/13/00. Within 24 hours, post vax, the pt developed vomiting, general myalgia and alternating feelings of hot and cold. She also developed an injection site reaction characterized by redness and swelling. The specific sites of vaccine administration, were not specified. This is 1 of 2 pts from this facility who had an adverse experience following receipt of Pnu-Imune 23 (lot 469133).
Age: 63.0
Sex: F
Vaccine: FLU3, PPV, FLU3, PPV
Symptoms: Vomiting
Clinical narrative: A nurse reported that a 63 year old female received Pnu-Imune 23 and Fluzone vaccines on 11/13/00. Within 24 hours, post vax, the pt developed vomiting, general myalgia and alternating feelings of hot and cold. She also developed an injection site reaction characterized by redness and swelling. The specific sites of vaccine administration, were not specified. This is 1 of 2 pts from this facility who had an adverse experience following receipt of Pnu-Imune 23 (lot 469133).
Age: 63.0
Sex: F
Vaccine: FLU3, PPV, FLU3, PPV
Symptoms: Injection site erythema, Injection site swelling, Myalgia, Pyrexia, Vomiting
Clinical narrative: A nurse reported that a 63 year old female received Pnu-Imune 23 and Fluzone vaccines on 11/13/00. Within 24 hours, post vax, the pt developed vomiting, general myalgia and alternating feelings of hot and cold. She also developed an injection site reaction characterized by redness and swelling. The specific sites of vaccine administration, were not specified. This is 1 of 2 pts from this facility who had an adverse experience following receipt of Pnu-Imune 23 (lot 469133).
Age: 79.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Arthralgia, Arthritis, Joint swelling, Polyarthritis
Clinical narrative: A nurse reported that a 79 year old female received Pnu-Imune 23 and Fluzone vaccines on 10/26/00. The following day, she developed pain, swelling and redness of her joints. The pt was dx'd with polyarthritis.
Age: 72.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Cellulitis, Injection site reaction
Clinical narrative: A nurse reported that a 72 year old pt received an injection of Pnu-Imune 23 and influenza virus vaccine on 11/1/00. Subsequently, the pt developed cellulitis at the site of Pnu-Imune 23 administration. The pt was treated with an unspecified antibiotic. This is 1 of 3 pts from this facility who developed an injection site reaction following receipt of Pnu-Imune 23 (lot 470588). Follow-up information received from the physician on 3/14/01, indicated that a 72 year old female developed the adverse event on 11/2/00. She was seen by the physician and recovered.
Age: 75.0
Sex: M
Vaccine: FLU3, PPV
Symptoms: Injection site swelling, Nausea, Pyrexia
Clinical narrative: A nurse reported that a 75 year old male received Pnu-Imune 23 and Fluvirin vaccines on 10/24/00. The reporter stated that the vaccines were administered after being mixed in the same syringe. Approx. 6 hours later, the pt developed a fever, nausea and swelling at the injection site. He recovered by 10/27/00.
Sex: M
Vaccine: FLU3, PPV
Symptoms: Cellulitis, Injection site reaction
Clinical narrative: A physician reported that a male pt received Pnu-Imune 23 and 1999-2000 formula influenza virus vaccines on 10/19/99. On 10/20/99, he developed cellulitis and was seen in the physician's office. He was prescribed an unspecified antibiotic. This is 1 of 2 pts from this facility who experienced this event following receipt of Pnu-Imune 23 (lot 459040); the other was serious. See related MCN HQ3303122OCT1999. Additional information received from the physician on 12/7/99, indicated that the pt recovered.
Age: 58.0
Sex: F
Vaccine: FLUX
Symptoms: Diarrhoea, Nausea
Clinical narrative: A 58 year old female received an injection of influenza virus vaccine in 10/76. One year, post vax, she developed hypersensitivity to the following; sulfa products, penicillin, Floxin, Cipro, codeine, clindamycin, Macrobid, generic Klonopin, blue dye, red dye #40, yellow dye FC #5 and #6, eggs, beef, bacitracin, proparacaine, lidocaine, Tobrex, fluoracaine, Acular, Ocuflox, Vexol and chlorine in the drinking water. Her hypersensitivity symptoms include: nausea and diarrhea. FOLLOW-UP information received fromthe patient on 08/27/01, indicated that she also developed a hypersensitivity to Bactorban and band-aids glue. FOLLOW-UP informationreceived from the patient on 05/09/02 indicated that her symptoms have not related.
Age: 10.0
Sex: M
Vaccine: HEP
Symptoms: Rash macular
Clinical narrative: Macular rash both forearms with a small amount on chest and face.
Age: 5.0
Sex: F
Vaccine: DTAP, IPV
Symptoms: Injection site erythema
Clinical narrative: 5" diameter red area at the site of injection.
Age: 32.0
Sex: F
Vaccine: PPV
Symptoms: Erythema, Injection site erythema, Injection site pain, Injection site swelling, Myalgia
Clinical narrative: A physician's assistant reported that a 32 year old female inadvertently received an intradermal injection of Pnu-Imune 23 on 8/14/00. Within 24 hours, she developed an injection site reaction characterized by a 12" X 4" area of redness, tenderness and swelling. She also had "severe" muscle pain in and around the area of erythema.
Age: 72.0
Sex: F
Vaccine: PPV
Symptoms: Headache, Injection site pain, Injection site swelling, Malaise, Pain
Clinical narrative: A daughter reported that her 72 year old mother received an injection of Pnu-Imune 23 on 8/21/00. Later that day, she developed an injection site reaction characterized by swelling and "severe" pain. She also developed a headache, malaise and generalized pain. Additional information received from the physician on 10/16/00, indicated that the pt did not report this to the physician's office.
Age: 8.0
Sex: M
Vaccine: MEN, PPV
Symptoms: Chills, Injection site erythema, Injection site pain, Nausea
Clinical narrative: An 8 year old male received an injection of Pnu-Imune 23 and meningococcal vaccines, each in different arms, on 2/18/00 and subsequently, developed chills, nausea and an injection site reaction at the Pnu-Imune 23 administration site characterized by a 1 3/4" X 1 1/2" area of erythema and pain. He was treated with acetaminophen and cortisone cream. His temperature was 99F.. Additional information received on 10/30/00, indicated that the pt was seen by a physician and recovered.
Sex: M
Vaccine: PPV
Symptoms: Drug ineffective, Immunoglobulins decreased
Clinical narrative: A nurse reported that a 53 year old male received 23-valent pneumococcal vaccine and "is not responding". Additional information received on 5/23/01, indicated that the pt has a history of IgG deficiency and "did not make an immune response" following receipt of 23-valent pneumococcal vaccine on 4/01 with his 1st dose. See HQ0004423APR2001.
Age: 66.0
Sex: F
Vaccine: PPV
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Pain
Clinical narrative: A healthcare professional reported that a 66 year old female received Pnu-Imune 23 on 5/3/01. Within hours, post vax, the pt developed an injection site reaction characterized by "severe" swelling, redness and pain from her shoulder to her fingertips. The pt was treated with applications of warm compresses. This is 1 of 2 pts from this facility who experienced this event, post vax, of Pnu-Imune 23 (lot 475387).
Age: 11.0
Sex: F
Vaccine: HEP, MMR, PPV
Symptoms: Injection site erythema, Injection site pain, Pyrexia
Clinical narrative: A pharmacist reported that an 11 year old female received Pnu-Imune 23, MMRII and Hep-B vaccines on 8/25/00 and subsequently, developed a fever and an injection site reaction characterized by redness and tenderness. She recovered. This is 1 of 2 pts from this facility who experienced this event following receipt of Pnu-Imune 23 (lot 463729).
Age: 77.0
Sex: F
Vaccine: PPV
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Pain
Clinical narrative: A healthcare professional reported that a 77 year old female received Pnu-Imune 23 on 4/25/01 and subsequently, developed an injection site reaction characterized by "severe" swelling, redness and pain from her shoulder to her fingertips for several days. The pt was treated with applications of warm compresses. This is 1 of 2 pts from this facility who experienced this event following receipt of Pnu-Imune 23 (lot 475387).
Age: 11.0
Sex: F
Vaccine: HIBV, PPV
Symptoms: Injection site erythema, Injection site pain, Pyrexia
Clinical narrative: A pharmacist reported that an 11 year old female received Pnu-Imune 23 and PROHIBIT vaccines on 8/24/00 and subsequently, developed a fever and an injection site reaction characterized by redness and tenderness. She recovered. This is 1 of 2 pts from this facility who experienced this event following receipt of Pnu-Imune 23 (lot 463729).
Age: 3.0
Sex: M
Vaccine: PPV
Symptoms: Injection site pain, Lymphadenopathy, Pyrexia, Viral infection
Clinical narrative: A pharmacist reported that her 3 year old son received 23-valent pneumococcal vaccine on 5/8/01. That evening, the child developed a "low grade" fever of 100F-101F, as well as, pain at the injection site. By the evening of 5/9/01, the child had a fever of 104F with swollen glands. He was treated with Tylenol and Motrin. On 5/10/01, the child was seen by the physician and was subsequently, treated with Augmentin. An unspecified strep culture, taken the same day, was reportedly negative. As of 5/11/01, the injection site pain had resolved, but the fever and swollen glands persisted. The reporter indicated that the child had a cold a "few weeks ago" and that his glands were "slightly" swollen prior to vaccination. Follow-up information received from the reporter on 7/2/01, indicated that a "blood test" for Epstein-Barr virus was positive. The reporter considered the event to be unrelated to 23-valent pneumococcal vaccine administration.
Age: 61.0
Sex: F
Vaccine: PPV
Symptoms: Bacterial infection, Bronchiectasis, Ear pain, Respiratory tract infection
Clinical narrative: A 64 year old female reported that she received a dose of pneumococcal vaccine in 1998 at the age of 61. She indicated that, the year following receipt of the vaccine, she developed a pneumococcal infection. She reported a chronic history of pneumonia, bronchiectasis, earaches and various respiratory infections. These illnesses developed after previous pneumococcal immunizations. No further information was available at the date of the report.
Sex: F
Vaccine: PPV
Symptoms: Injection site hypersensitivity, Injection site oedema, Injection site pain
Clinical narrative: A physician reported that a female in her late 70's received an injection of Pnu-Imune 23 on 04/19/00. Immediately post-vaccination, she developed an injection site reaction characterized by swelling, pain , and redness. This is 1 of 2 patients from this facility who experienced this event following receipt of Pnu-Imune 23 lot 458-744.
Age: 11.0
Sex: F
Vaccine: PPV
Symptoms: Cellulitis, Injection site oedema, Injection site pain, Injection site reaction, Musculoskeletal stiffness
Clinical narrative: A nurse reported that an 11.5 year old female with a medical history of asthma received an injection of Pnu-Imune 23 on 05/14/01. That same day, she developed an injection site reaction characterized by left leg stiffness and swelling. On 05/15/01, the patient developed a red rash the size of a small dinner plate, swelling and tenderness at the injection site. She was seen by the physician that day and a diagnosis of cellulitis was made. She was treated with Cephalexin for 10 days. This is 1 of 2 patients from this facility who experienced cellulitis following experienced this event following receipt of Pnu-Imune 23 lot 463-748.The patient recovered.
Age: 11.0
Sex: F
Vaccine: PPV
Symptoms: Oedema peripheral, Rash erythematous
Clinical narrative: A nurse reported that an 11.5 year old female with a medical history of asthma received an injection of Pnu-Imune 23 on 05/14/01. That same day, she developed an injection site reaction characterized by left leg stiffness and swelling. On 05/15/01, the patient developed a red rash the size of a small dinner plate, swelling and tenderness at the injection site. She was seen by the physician that day and a diagnosis of cellulitis was made. She was treated with Cephalexin for 10 days. This is 1 of 2 patients from this facility who experienced cellulitis following experienced this event following receipt of Pnu-Imune 23 lot 463-748.The patient recovered.
Age: 66.0
Sex: M
Vaccine: PPV
Symptoms: Injection site erythema, Injection site oedema, Injection site warmth
Clinical narrative: A healthcare professional reported that a 66 year old male received an injection of Pnu-Imune 23 on 01/22/01. The same day, the patient  developed an injection site reaction characterized by swelling, redness, and warmth which extended to his hand. The patient was treated with applications of warm compresses, which reportedly did not relieve his symptoms. On 01/25/01, he was prescribed Medrol Dosepak. This is 1 of 2 patients from this facility who developed an injection site reaction following receipt of Pnu-Imune 23 lot 469-132.
Age: 81.0
Sex: F
Vaccine: PPV
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: A physician reported that an 81 year old female received an injection of Pnu-Imune 23 on 4/19/00. Immediately, post vax, she developed an injection site reaction characterized by redness, pain and swelling. This is 1 of 2 pts from this facility, who experienced this event following receipt of Pnu-Imune 23, lot 458744.
Age: 85.0
Sex: M
Vaccine: PPV
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: A nurse reported that an 85 year old male received his 2nd dose of Pnu-Imune 23 on 4/3/01. Within 48 hours, he developed an injection site reaction characterized by redness and swelling which extended to his elbow. The pt was treated "symptomatically" and he recovered. No further information was available at the date of this report. MANUFACTURER'S COMMENT: This is 1 of 2 pts from this facility who developed an injection site reaction following receipt of Pnu-Imune 23, lot 470592. See related HQ9390306APR2001. FOLLOW-UP information was received from the nurse on 07/13/01. The reporter indicated that the patient was unable to sleep for two night due to discomfort.the reporter noted that a third patient from this facility developed an injection site reaction following receipt of Pnu-imune 23, lot number 470-592. See related case HQ3493419JUL2001.
Age: 78.0
Sex: F
Vaccine: PPV
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth, Pruritus
Clinical narrative: A nurse reported that a 78 year old female received an injection of Pnu-Imune 23 on 4/4/01 and subsequently, developed an injection site reaction characterized by redness, warmth, swelling and itchiness that extended from her deltoid to her forearm. The pt returned to the physician's office, 2 hours, post vax, and was treated with Benadryl. The redness, swelling and itchiness resolved. As of 4/12/01, a "small warm area" at the site of Pnu-Imune 23 administration persisted. This is 1 of 2 pts from this facility who developed an injection site reaction following receipt of Pnu-Imune 23, lot 474936.
Sex: U
Vaccine: PPV
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: A pharmacist reported that a pt received an injection of Pnu-Imune 23 on 5/22/01 and subsequently, developed an injection site reaction characterized by redness, warmth and swelling. The reporter indicated that 2 pts experienced this reaction following receipt of Pnu-Imune 23 vaccine, lot 468147. Additional reports will be generated when identifying information is received. No further information was available at the date of this report.
Age: 70.0
Sex: M
Vaccine: PPV
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: A nurse reported that a 70 year old male received an injection of Pnu-Imune 23 on 5/23/01. On 5/24/01, he developed an injection site reaction characterized by redness, swelling and heat. This is 1 of 2 pts from this facility who experienced this event following receipt of Pnu-Imune 23, lot 472209.
Age: 42.0
Sex: F
Vaccine: PPV
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: A nurse reported that a 42 year old female received an injection of Pnu-Imune 23 on 4/20/01. On 4/21/01, she developed an injection site reaction characterized by redness, swelling and heat. This is 1 of 2 pts from this facility who experienced this event following receipt of Pnu-Imune 23, lot 472209.
Age: 41.0
Sex: F
Vaccine: PPV
Symptoms: Alanine aminotransferase increased, Anaemia, Blood alkaline phosphatase increased, Blood creatinine increased, Flushing
Clinical narrative: On 5/20/01, pt developed swollen joints, facial flushing and itching of the hands and feet. She was seen in the ER. Additional information recvd from MD on 6/19/01 indicated that the pt was treated with prednisone tapered over 2 wks and diphenhydramine. She recovered.
Age: 41.0
Sex: F
Vaccine: PPV
Symptoms: Hypochromic anaemia, Joint swelling, Pruritus, Red blood cell sedimentation rate increased
Clinical narrative: On 5/20/01, pt developed swollen joints, facial flushing and itching of the hands and feet. She was seen in the ER. Additional information recvd from MD on 6/19/01 indicated that the pt was treated with prednisone tapered over 2 wks and diphenhydramine. She recovered.
Age: 45.0
Sex: F
Vaccine: PPV
Symptoms: Hypoaesthesia, Nausea, Vomiting
Clinical narrative: A nurse reported that a 45 year old female received an injection of Pnu-Imune 23 on 98/18/00. On 09/20/00, she developed nausea, vomiting and numbness in her chest and stomach. Her symptoms resolved prior to being seen by the physician on 10/02/00. Additional info received on 11/15/00 indicated that the patient was allergic to x-ray dye, nitrofurantoin, sulfa, aspirin, hydrocodone / acetaminiphen, oxycodone / acetaminophen and troglitazone.
Age: 43.0
Sex: F
Vaccine: PPV
Symptoms: Chest discomfort, Choking, Dyspnoea, Injection site erythema, Injection site induration
Clinical narrative: Approximately 24 hours post vax, pt developed an injection site reaction characterized by redness and induration. The pt also developed a fever of 101F that lasted for 1-2 days, then a fever of 99-100F. She also experienced malaise, shortness of breath, a choking sensation and chest tightness. The reporter stated that the injection site reaction had resolved, but the other events are "ongoing to a lesser degree." The MD noted that these events "may be related" to an injection of MMR that the pt recvd 1 wk earlier. A copy of this report has been forwarded to Merck, manufacturer of MMR.
Age: 43.0
Sex: F
Vaccine: PPV
Symptoms: Malaise, Pyrexia
Clinical narrative: Approximately 24 hours post vax, pt developed an injection site reaction characterized by redness and induration. The pt also developed a fever of 101F that lasted for 1-2 days, then a fever of 99-100F. She also experienced malaise, shortness of breath, a choking sensation and chest tightness. The reporter stated that the injection site reaction had resolved, but the other events are "ongoing to a lesser degree." The MD noted that these events "may be related" to an injection of MMR that the pt recvd 1 wk earlier. A copy of this report has been forwarded to Merck, manufacturer of MMR.
Age: 33.0
Sex: M
Vaccine: HEPA, PPV
Symptoms: Injection site erythema, Injection site induration, Nausea, Pyrexia, Vomiting
Clinical narrative: A nurse reported that a 33 year old male received Pnu-Imune 23 and Hep-A vaccines on 4/4/01. Later that evening, he developed an injection site reaction characterized by a 30mm area of redness and induration and inability to move his arm. He also experienced nausea and vomiting and developed a fever of 101F. The symptoms lasted about 2 days. No further information was available at the date of this report. The reporter indicated that 4 pts experienced these events following receipt of Pnu-Imune 23, lot 469401. (See HQ9560211APR2001, HQ1777407JUN2001 and HQ1777507JUN2001).
Age: 40.0
Sex: F
Vaccine: PPV
Symptoms: Hypokinesia, Injection site erythema, Injection site induration, Nausea, Pyrexia
Clinical narrative: A nurse reported that a 40 year old female received an injection of Pnu-Imune 23 on 4/6/01. That same day, she developed an injection site reaction characterized by a 30mm area of redness and induration and inability to move her arm. She experienced nausea and vomiting and developed a fever of 101F. She recovered. No further information was available at the date of the report. This is 1 of 4 pts from this facility who experienced these events following receipt of Pnu-Imune 23, lot 469401. (See HQ9560211APR2001, HQ1777307JUN2001 and HQ1777507JUN2001).
Age: 40.0
Sex: F
Vaccine: PPV
Symptoms: Vomiting
Clinical narrative: A nurse reported that a 40 year old female received an injection of Pnu-Imune 23 on 4/6/01. That same day, she developed an injection site reaction characterized by a 30mm area of redness and induration and inability to move her arm. She experienced nausea and vomiting and developed a fever of 101F. She recovered. No further information was available at the date of the report. This is 1 of 4 pts from this facility who experienced these events following receipt of Pnu-Imune 23, lot 469401. (See HQ9560211APR2001, HQ1777307JUN2001 and HQ1777507JUN2001).
Sex: F
Vaccine: PPV
Symptoms: Hypokinesia, Injection site erythema, Injection site induration, Nausea, Pyrexia
Clinical narrative: A nurse reported that a female, approx. 26-27 years of age, received an injection of Pnu-Imune 23 (date not specified). Within hours, post vax, she developed an injection site reaction characterized by a 30mm area of redness and induration and inability to move her arm. She experienced nausea and vomiting and developed a fever of 101F. The symptoms resolved within a few days. No further information was available at the date of the report. The reporter indicated that 4 pts experienced these events following receipt of Pnu-Imune 23, lot 469401. (See HQ9560211APR2001, HQ1777307JUN2001 and HQ1777407JUN2001).
Sex: F
Vaccine: PPV
Symptoms: Vomiting
Clinical narrative: A nurse reported that a female, approx. 26-27 years of age, received an injection of Pnu-Imune 23 (date not specified). Within hours, post vax, she developed an injection site reaction characterized by a 30mm area of redness and induration and inability to move her arm. She experienced nausea and vomiting and developed a fever of 101F. The symptoms resolved within a few days. No further information was available at the date of the report. The reporter indicated that 4 pts experienced these events following receipt of Pnu-Imune 23, lot 469401. (See HQ9560211APR2001, HQ1777307JUN2001 and HQ1777407JUN2001).
Sex: U
Vaccine: PPV
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: A MA reported that a pt received an injection of Pnu-Imune 23 in 9/00. Subsequently, the pt developed an injection site reaction characterized by a "large" red, swollen area that was "hot to the touch". The swelling extended from shoulder to elbow. The pt recovered. The reporter indicated that 3 pts experienced this event; however, they are not presently identifiable. Additional reports will be generated when identifying information information is provided.
Age: 1.5
Sex: U
Vaccine: PPV
Symptoms: Pyrexia
Clinical narrative: A pharmacist reported that an 18 month old child inadvertently, received an injection of Pnu-Imune 23. The next day, the child developed a minor fever. No further information was available at the date of this report.
Age: 62.0
Sex: F
Vaccine: PPV
Symptoms: Cellulitis, Injection site reaction
Clinical narrative: A nurse reported that a 62 year old female received an injection of Pnu-Imune 23 on 9/29/00. On 10/2/00, she was dx'd with cellulitis. The pt was treated with Keflex. The reporter indicated that 2 pt's experienced a "cellulitis reaction"; however, they are not presently identifiable. An additional report will be generated when identifying information is provided.
Age: 65.0
Sex: F
Vaccine: PPV, TD
Symptoms: Cellulitis, Injection site reaction
Clinical narrative: A healthcare professional reported that a 65 year old female received an injection of Pnu-Imune 23 and Tetanus Toxoid vaccines on 7/19/00. The next day, the pt developed an injection site reaction at the site of the Pnu-Imune 23 administration. She was dx'd with cellulitis and treated with Rocephin and Keflex. This is 1 of 2 pts from this facility who experienced this event following receipt of Pnu-Imune 23, lot 462810.
Age: 28.0
Sex: M
Vaccine: HIBV, PPV
Symptoms: Headache, Injection site erythema, Injection site induration, Injection site pain, Injection site warmth
Clinical narrative: A pharmacist reported that a 28 year old male received Pnu-Imune 23 and Hib-Titer vaccines on 10/1/00. The next day, he developed a severe headache and a fever of 102F. He also developed soreness at the injection site. On 10/3/00, the injection site reaction included a 6" X 3" area of warmth, redness and induration. The fever and headache resolved in 2 days.
Age: 28.0
Sex: M
Vaccine: HIBV, PPV
Symptoms: Pyrexia
Clinical narrative: A pharmacist reported that a 28 year old male received Pnu-Imune 23 and Hib-Titer vaccines on 10/1/00. The next day, he developed a severe headache and a fever of 102F. He also developed soreness at the injection site. On 10/3/00, the injection site reaction included a 6" X 3" area of warmth, redness and induration. The fever and headache resolved in 2 days.
Age: 68.0
Sex: F
Vaccine: PPV
Symptoms: Injection site erythema, Injection site induration, Injection site pain, Lymphadenopathy, Pruritus
Clinical narrative: A pharmacist reported that a female received an injection of Pnu-Imune 23 on 10/6/00 and subsequently, developed an injection site reaction characterized by pain, erythema and hardness. As of 10/13/00, the pain persisted. The reporter indicated that 2 females experienced this event; however, they are not presently identifiable. Additional reports will be generated when identifying information is provided. Additional information received from the physician's office on 11/20/00, indicated that the pt is a 68 year old female, immunized on 10/5/00. On 10/6/00, she developed a fever, enlarged axillary glands, itching, skin peeling and shoulder pain. She recovered.
Age: 68.0
Sex: F
Vaccine: PPV
Symptoms: Pyrexia, Skin exfoliation
Clinical narrative: A pharmacist reported that a female received an injection of Pnu-Imune 23 on 10/6/00 and subsequently, developed an injection site reaction characterized by pain, erythema and hardness. As of 10/13/00, the pain persisted. The reporter indicated that 2 females experienced this event; however, they are not presently identifiable. Additional reports will be generated when identifying information is provided. Additional information received from the physician's office on 11/20/00, indicated that the pt is a 68 year old female, immunized on 10/5/00. On 10/6/00, she developed a fever, enlarged axillary glands, itching, skin peeling and shoulder pain. She recovered.
Age: 71.0
Sex: F
Vaccine: PPV
Symptoms: Injection site erythema, Injection site swelling, Pruritus
Clinical narrative: A nurse reported that a 71 year old female received an injection of Pnu-Imune 23 on 10/2/00 and subsequently, developed an injection site reaction characterized by redness, swelling and itching. The pt's husband insists that his wife received Pnu-Imune 23, 1 year ago; however, the pt does not remember this. She recovered.
Age: 74.0
Sex: F
Vaccine: PPV
Symptoms: Cellulitis, Injection site reaction
Clinical narrative: A MA reported that a pt received a dose of Pnu-Imune 23 vaccine in 6/01 and subsequently, developed cellulitis. The pt was seen in the ER and was prescribed antibiotics. The pt recovered. The reporter indicated that 3 or 4 pts experienced this event following receipt of Pnu-Imune 23, lot 468147. (See HQ3428718JUL2001 and HQ3428818JUL2001).
Age: 73.0
Sex: F
Vaccine: PPV
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: A nurse reported that a 73 year old female received an injection of Pnu-Imune 23 on 10/16/00 and subsequently developed an injection site reaction characterized by redness and soreness. On 10/17/00, the swelling, redness and pain was more severe, extending from slightly above the injection site down to her wrist and involving the hand. She was seen by the physician and treated with hydroxyzine and applications of cold compresses. Additional information received on 1/5/01, indicated that the pt recovered.